An Engineered Allogeneic Artificial Antigen-Presenting Red Cell Therapeutic, RTX-321, Promotes Antigen-Specific T Cell Expansion and Anti-Tumor Activity

Xuqing Zhang, Mengyao Luo, Shamael R. Dastagir, Mellissa Nixon, Albert Lee, Andrea Schmidt, Annie Khamhoung, Douglas C. McLaughlin, Chris Moore, Sneha Pawar, Timothy J. Lyford, Mary Gribble, Viral Amin, Christopher L. Carpenter, Thomas J. Wickham, and Tiffany F. Chen